524661
WELCURE
Start SIP
Invest Now
Start SIP in WELCURE
Performance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹1
- Open Price₹0
- Previous Close₹0
- Volume1,727,754
- 50 DMA₹0.41
- 100 DMA₹0.52
- 200 DMA₹0.63
Investment Returns
- Over 1 Month -16.67%
- Over 3 Month -36.36%
- Over 6 Month -61.96%
- Over 1 Year -62.77%
Smart Investing Starts Here Start SIP with Welcure Drugs & Pharmaceuticals for Steady Growth!
Welcure Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 1.2
- PEG Ratio
- 0
- Market Cap Cr
- 43
- P/B Ratio
- 0.3
- Average True Range
- 0.02
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.03
- RSI
- 45.71
- MFI
- 28.05
Welcure Drugs & Pharmaceuticals Financials
Welcure Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹0.35
+
0.01
(2.94%)
- Bearish Moving Average 10
- Bullish Moving Average 6
- 20 Day
- ₹0.35
- 50 Day
- ₹0.41
- 100 Day
- ₹0.52
- 200 Day
- ₹0.63
Resistance and Support
0.35
- R3 0.35
- R2 0.35
- R1 0.35
- S1 0.35
- S2 0.35
- S3 0.35
Welcure Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-12 | Quarterly Results | |
| 2025-12-05 | Right Issue of Equity Shares | |
| 2025-11-27 | To consider raisinf of funds | Inter-alia, 1. To augment the financial resources of the Company via funds raising by way of issue of equity shares/convertible instruments/other securities through permissable modes. split from Rs. 10/- to Re. 1/-. |
| 2025-11-13 | Quarterly Results | |
| 2025-09-27 | Others | Inter-alia, 1. To take on record and deliberate upon the Letter of Intent (LOI) received from Telexcell Trade PTE LTD, Singapore, for a proposed acquisition of up to 25% equity stake (Revised) split from Rs. 10/- to Re. 1/-. |
Welcure Drugs & Pharmaceuticals F&O
About Welcure Drugs & Pharmaceuticals
- NSE Symbol
- WELCURE
- BSE Symbol
- 524661
- Managing Director
- Mr. Chintan Didawala
- ISIN
- INE331C01025
Similar Stocks to Welcure Drugs & Pharmaceuticals
Welcure Drugs & Pharmaceuticals FAQs
Welcure Drugs & Pharmaceuticals share price is ₹0 As on 11 February, 2026 | 02:25
The Market Cap of Welcure Drugs & Pharmaceuticals is ₹43.3 Cr As on 11 February, 2026 | 02:25
The P/E ratio of Welcure Drugs & Pharmaceuticals is 1.2 As on 11 February, 2026 | 02:25
The PB ratio of Welcure Drugs & Pharmaceuticals is 0.3 As on 11 February, 2026 | 02:25
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.